Program landing page
Similar Posts
Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure
FDA’s surrogate endpoint table provides valuable information for drug developers on endpoints that may be considered and discussed with FDA for individual development programs.FDA Grand Rounds – Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces – 05/29/2025
Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces, May 29, 2025.MKS Enterprise, LLC – 624478 – 07/01/2022
Interstate Commerce/Food/Adulterated17th Annual Sentinel Initiative Public Workshop – 11/06/2025
The U.S. Food and Drug Administration, under a cooperative agreement with the Duke-Margolis Institute for Health Policy, is hosting the 16th Annual Sentinel Initiative Public Workshop on November 6, 2025Force Forever may be harmful due to hidden drug ingredients
Consumers should not to purchase or use Force Forever, a product promoted and sold for joint painMacsen Drugs – 698202 – 03/05/2025
CGMP/Finished Pharmaceuticals/Adulterated